Convalescent Plasma Antibody Levels and Covid-19

Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19) under the presumption that such plasma contains potentially therapeutic antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can be passively transferred to the plasma recipient. Dr. Michael Joyner discusses whether convalescent plasma with high antibody levels rather than low antibody levels is associated with a lower risk of death.

Image courtesy of Michael Joyner

Image courtesy of interviewee

Leave a Reply

Your email address will not be published.

×
Guest visitors to the Faculti website can view any insight monthly. You have insight(s) remaining for this month

Register for free as an individual and view thousands of insights in our archive today or subscribe for subject access.

You may already have institutional access to Faculti. Please access Faculti using your institution credentials.

Copyright © Faculti Media Limited 2022. All rights reserved.
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×